CLINICAL RESEARCH: HEART RHYTHM DISORDER
Lead Extraction in the Contemporary Setting: The LExICon StudyAn Observational Retrospective Study of Consecutive Laser Lead Extractions
Oussama Wazni, MD*,*,
Laurence M. Epstein, MD ,
Roger G. Carrillo, MD ,
Charles Love, MD ,
Stuart W. Adler, MD||,
David W. Riggio, MD¶,
Shahzad S. Karim, MD#,
Jamil Bashir, MD#,
Arnold J. Greenspon, MD**,
John P. DiMarco, MD, PhD ,
Joshua M. Cooper, MD ,
John R. Onufer, MD||||,
Kenneth A. Ellenbogen, MD¶¶,
Stephen P. Kutalek, MD ,
Sherri Dentry-Mabry, MSN##,
Carolyn M. Ervin, PhD## and
Bruce L. Wilkoff, MD*
* Department of Cardiovascular Disease, Cleveland Clinic, Cleveland, Ohio
Ohio State University, Columbus, Ohio
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
Mt. Sinai Medical Center, New York, New York
|| St. Paul Heart Clinic, St. Paul, Minnesota
¶ Arizona Heart Hospital, Phoenix, Arizona
# University of British Columbia, Vancouver, British Columbia, Canada
** Thomas Jefferson University, Philadelphia, Pennsylvania
 University of Pennsylvania, Philadelphia, Pennsylvania
 Drexel College of Medicine, Philadelphia, Pennsylvania
 University of Virginia, Charlottesville, Virginia
|||| Sentara Cardiovascular Research, Norfolk, Virginia
¶¶ Virginia Commonwealth University, Richmond, Virginia
## Spectranetics Corporation, Colorado Springs, Colorado
Manuscript received April 10, 2009;
revised manuscript received July 13, 2009,
accepted August 3, 2009.
* Reprint requests and correspondence: Dr. Oussama M. Wazni, Cleveland Clinic, Department of Cardiovascular Medicine/J2-2, 9500 Euclid Avenue, Cleveland, Ohio 44195 (Email: waznio{at}ccf.org).
Objectives: This study sought to examine the safety and efficacy of laser-assisted lead extraction and the indications, outcomes, and risk factors in a large series of consecutive patients.
Background: The need for lead extraction has been increasing in direct relationship to the increased numbers of cardiovascular implantable electronic devices.
Methods: Consecutive patients undergoing transvenous laser-assisted lead extraction at 13 centers were included.
Results: Between January 2004 and December 2007, 1,449 consecutive patients underwent laser-assisted lead extraction of 2,405 leads (20 to 270 procedures/site). Median implantation duration was 82.1 months (0.4 to 356.8 months). Leads were completely removed 96.5% of the time, with a 97.7% clinical success rate whereby clinical goals associated with the indication for lead removal were achieved. Failure to achieve clinical success was associated with body mass index <25 kg/m2 and low extraction volume centers. Procedural failure was higher in leads implanted for >10 years and when performed in low volume centers. Major adverse events in 20 patients were directly related to the procedure (1.4%) including 4 deaths (0.28%). Major adverse effects were associated with patients with a body mass index <25 kg/m2. Overall all-cause in-hospital mortality was 1.86%; 4.3% when associated with endocarditis, 7.9% when associated with endocarditis and diabetes, and 12.4% when associated with endocarditis and creatinine 2.0. Indicators of all-cause in-hospital mortality were pocket infections, device-related endocarditis, diabetes, and creatinine 2.0.
Conclusions: Lead extraction employing laser sheaths is highly successful with a low procedural complication rate. Total mortality is substantially increased with pocket infections or device-related endocarditis, particularly in the setting of diabetes, renal insufficiency, or body mass index <25 kg/m2. Centers with smaller case volumes tended to have a lower rate of successful extraction.
Key Words: leads cardiac implantable electronic devices extraction laser
|
Abbreviations and Acronyms
| | BMI = body mass index | | CIED = cardiovascular implantable electronic device | | DRE = device-related endocarditis | | LALE = laser-assisted lead extraction | | MAE = major adverse event | | NASPE = North American Society of Pacing and Electrophysiology |
|
Related Article
-
Inside This Issue
J. Am. Coll. Cardiol. 2010 55: A32.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Greenspon, J. M. Prutkin, M. R. Sohail, H. R. Vikram, L. M. Baddour, S. B. Danik, J. Peacock, C. Falces, J. M. Miro, E. Blank, et al.
Timing of the Most Recent Device Procedure Influences the Clinical Outcome of Lead-Associated Endocarditis: Results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort)
J. Am. Coll. Cardiol.,
February 14, 2012;
59(7):
681 - 687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. de Bie, D. A. Fouad, C. J. W. Borleffs, J. B. van Rees, J. Thijssen, S. A. Trines, M. Bootsma, M. J. Schalij, and L. van Erven
Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures
Europace,
January 1, 2012;
14(1):
112 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors (EHRA Task Force Members), J. C. Deharo, M. G. Bongiorni, A. Rozkovec, F. Bracke, P. Defaye, I. Fernandez-Lozano, P. G. Golzio, B. Hansky, C. Kennergren, et al.
Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper
Europace,
January 1, 2012;
14(1):
124 - 134.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Rodriguez, J. D. Garisto, and R. G. Carrillo
Laser Lead Extraction in the Octogenarian Patient
Circ Arrhythm Electrophysiol,
October 1, 2011;
4(5):
719 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kojodjojo, R. M. John, and L. M. Epstein
Disseminated malignancies masquerading as cardiovascular implantable electronic devices infections
Europace,
June 1, 2011;
13(6):
821 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. van Gelder and F. A. Bracke
Extraction of a coronary sinus atrioverter and a dual-coil ventricular shock lead from the same patient: a tailored approach
Europace,
May 1, 2011;
13(5):
756 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Oto, K. Aytemir, H. Yorgun, U. Canpolat, E. B. Kaya, G. Kabakci, L. Tokgozoglu, and H. Ozkutlu
Percutaneous extraction of cardiac pacemaker and implantable cardioverter defibrillator leads with evolution mechanical dilator sheath: a single-centre experience
Europace,
April 1, 2011;
13(4):
543 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maytin and L. M. Epstein
The challenges of transvenous lead extraction
Heart,
March 1, 2011;
97(5):
425 - 434.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Maisel and D. B. Kramer
Extracting Guidance From Extraction Data
J. Am. Coll. Cardiol.,
August 17, 2010;
56(8):
651 - 652.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Henrikson, M. Maytin, and L. M. Epstein
Think Before You Pull--Not Every Lead Has to Come Out
Circ Arrhythm Electrophysiol,
August 1, 2010;
3(4):
409 - 412.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maytin, L. M. Epstein, and C. A. Henrikson
Lead Extraction Is Preferred for Lead Revisions and System Upgrades: When Less Is More
Circ Arrhythm Electrophysiol,
August 1, 2010;
3(4):
413 - 424.
[Full Text]
[PDF]
|
 |
|
|